LIVALO pitavastatin 1 mg film-coated tablet blister pack

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

pitavastatin calcium, Quantity: 1.045 mg (Equivalent: pitavastatin, Qty 1 mg)

Prieinama:

Advantage Medical Products Consulting Pty Ltd

INN (Tarptautinis Pavadinimas):

pitavastatin calcium

Vaisto forma:

Tablet, film coated

Sudėtis:

Excipient Ingredients: hyprolose; titanium dioxide; triethyl citrate; hypromellose; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; aluminium magnesium silicate

Vartojimo būdas:

Oral

Vienetai pakuotėje:

100, 10, 30, 28

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

Livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. Prior to initiating therapy with Livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Produkto santrauka:

Visual Identification: Round biconvex white film-coated tablets embossed on one side with 'KC' and '1' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorizacija statusas:

Licence status A

Leidimo data:

2013-08-27